Neuraxis, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
NeurAxis, Inc. has issued its 2026 proxy statement detailing proposals for director elections, auditor ratification, and significant equity plan amendments.
AMEX
Neuraxis, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pursuant to Section 14(a) of the Securities Exchange Act of 1934.
AMEX
Neuraxis, Inc. announces its 2025 Annual Meeting of Stockholders to be held on May 29, 2025, to elect directors, ratify the appointment of the accounting firm, and approve the issuance of common stock upon conversion of preferred stock.
AMEX
Neuraxis, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
AMEX
Neuraxis, Inc. is holding its annual meeting on August 15, 2024, seeking stockholder approval on several key proposals, including director elections, auditor ratification, and amendments to the company's incentive plan and certificate of incorporation.